Unknown

Dataset Information

0

Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study.


ABSTRACT: OBJECTIVE:Understand how insurance impacts access to services among people who have injected drugs. METHODS:1748 adults who have injected drugs were assessed at twice-annual study visits between 2006 and 2017 (18,869 visits). Use of specialty substance use treatment, receipt of buprenorphine, and having a regular source of medical care were assessed for association with concurrent insurance coverage. Random intercept logistic regression was used to adjust for potential confounders. RESULTS:When participants acquired insurance, they were more likely to report specialty substance use treatment (aOR 2.0, 95% CI 1.6 to 2.5), a buprenorphine prescription (aOR 3.3, 95% CI 2.0 to 5.5), and a regular source of medical care (aOR 6.3, 95% CI 5.1 to 7.8). CONCLUSION:Insurance is associated with increased use of three important services for individuals who inject drugs. IMPLICATIONS:Expanding insurance may facilitate access to substance use treatment and other needed health services.

SUBMITTER: Feder KA 

PROVIDER: S-EPMC6556110 | BioStudies | 2019-01-01

SECONDARY ACCESSION(S): 10.18637/jss.v067.i01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6330240 | BioStudies
2020-01-01 | S-EPMC7053738 | BioStudies
2020-01-01 | S-EPMC7171554 | BioStudies
2014-01-01 | S-EPMC4189808 | BioStudies
2018-01-01 | S-EPMC6354252 | BioStudies
2020-01-01 | S-EPMC7504160 | BioStudies
2017-01-01 | S-EPMC5555852 | BioStudies
2018-01-01 | S-EPMC6101399 | BioStudies
2017-01-01 | S-EPMC5559779 | BioStudies
2020-01-01 | S-EPMC7065783 | BioStudies